Fluoroquinolones in upper respiratory tract infections

Comment

M Spiteri. BMJ. 1994.

. 1994 Mar 5;308(6929):657-8.

doi: 10.1136/bmj.308.6929.657c.

No abstract available

Comment on

Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.
Körner RJ, Reeves DS, MacGowan AP. Körner RJ, et al. BMJ. 1994 Jan 15;308(6922):191-2. doi: 10.1136/bmj.308.6922.191. BMJ. 1994. PMID: 8312775 Free PMC article. No abstract available.

[Fluoroquinolones in the treatment of respiratory infections].
Stahlmann R. Stahlmann R. Pneumologie. 1999 Nov;53(11):521-9. doi: 10.1055/s-1999-9244. Pneumologie. 1999. PMID: 10613068 Review. German. No abstract available.
Role of newer fluoroquinolones in lower respiratory tract infections.
Lode H, Allewelt M. Lode H, et al. J Antimicrob Chemother. 2002 May;49(5):709-12. doi: 10.1093/jac/dkf024. J Antimicrob Chemother. 2002. Corrected and republished in: J Antimicrob Chemother. 2002 Jul;50(1):151-4. doi: 10.1093/jac/dkf133. PMID: 12003962 Corrected and republished. Review. No abstract available.
Newer fluoroquinolones and the management of respiratory tract infections.
Karchmer AW. Karchmer AW. Clin Infect Dis. 2000 Aug;31 Suppl 2:S15. doi: 10.1086/314055. Clin Infect Dis. 2000. PMID: 10984322 Review. No abstract available.
Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae.
Amyes SG, Thomson CJ. Amyes SG, et al. J Antimicrob Chemother. 1998 Sep;42(3):398-9. doi: 10.1093/jac/42.3.398. J Antimicrob Chemother. 1998. PMID: 9786483 No abstract available.
[The role of respiratory quinolone in treatment of respiratory tract infections: focusing on gatifloxacin].
Kohno S, Watanabe A, Matsushima T. Kohno S, et al. Jpn J Antibiot. 2002 Jun;55(3):247-58. Jpn J Antibiot. 2002. PMID: 12199109 Japanese. No abstract available.